| P50 | author | Pamela Russell | Q18166584 |
| | Benita Katzenellenbogen | Q47027827 |
| | Christine L. Clarke | Q56204859 |
| P2093 | author name string | Michael Friedlander | |
| | Katherine M Tucker | |
| | Karen Byth | |
| | Anna de Fazio | |
| | Lyndal Edwards | |
| | Morteza Aghmesheh | |
| P2860 | cites work | BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor | Q24555775 |
| | Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B | Q24556548 |
| | Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells | Q24675586 |
| | Role of direct interaction in BRCA1 inhibition of estrogen receptor activity | Q28204456 |
| | Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues | Q28264982 |
| | Detection of progesterone receptor forms A and B by immunohistochemical analysis | Q28345003 |
| | Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites | Q29620551 |
| | Emerging roles of BRCA1 in transcriptional regulation and DNA repair | Q33755145 |
| | Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways | Q33872599 |
| | Tumour biological features of BRCA1-induced breast and ovarian cancer | Q73347724 |
| | Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status | Q73639853 |
| | Clinicopathologic features of BRCA-linked and sporadic ovarian cancer | Q73782102 |
| | Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study | Q73936350 |
| | Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel | Q74223498 |
| | Absence of estrogen receptor-beta expression in metastatic ovarian cancer | Q74228747 |
| | Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers | Q74405501 |
| | Frequency of BRCA1 dysfunction in ovarian cancer | Q77438333 |
| | Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone | Q77636062 |
| | Hormone therapy in epithelial ovarian cancer | Q33974001 |
| | Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer | Q34113283 |
| | Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat | Q34389571 |
| | Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses | Q35395878 |
| | Pathology of ovarian cancers in BRCA1 and BRCA2 carriers | Q35741630 |
| | Sex hormones in women in rural China and in Britain | Q35982094 |
| | Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells | Q36367092 |
| | Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies | Q36621572 |
| | Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling? | Q36622899 |
| | Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis | Q38456582 |
| | Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden | Q38503154 |
| | Involvement of estrogen receptor beta in ovarian carcinogenesis | Q40524990 |
| | Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels | Q41710485 |
| | Reduction of BRCA1 expression in sporadic ovarian cancer | Q41720959 |
| | Human estrogen receptor beta-specific monoclonal antibodies: characterization and use in studies of estrogen receptor beta protein expression in reproductive tissues | Q43690371 |
| | The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. | Q43974233 |
| | Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures | Q44513339 |
| | Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. | Q44772380 |
| | Improved survival in women with BRCA-associated ovarian carcinoma | Q46693199 |
| | Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations | Q47696751 |
| | Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group | Q47701078 |
| | Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues | Q48051121 |
| | BRCA1 mutations in familial ovarian cancer. | Q52914528 |
| | Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. | Q54417578 |
| | Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers | Q59689039 |
| | Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors | Q60300155 |
| | BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells | Q60568779 |
| | Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1 | Q63183299 |
| | An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors | Q63966407 |
| | Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen | Q67446195 |
| | An epidemiologic study of epithelial carcinoma of the ovary | Q70992532 |
| | A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome | Q72143105 |
| | Steroid hormone receptors and long term survival in invasive ovarian cancer | Q73104116 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 16-25 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas | |
| P478 | volume | 97 | |